# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hepatitis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 111-120 of 500 results.
Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea
Status: Recruiting
Last Changed: Nov 04, 2020
First Received: Nov 01, 2016
Disease(s): Hepatitis C Virus
Intervention(s): LDV/SOF
Locations: Konkuk University Chungju Hospital, Chungju-si, Chungcheongbuk-do, Korea, Republic of
Soonchunhyang University Cheonan Hospital, Cheonan, Chungcheongnam-do, Korea, Republic of
Hallym University ChunCheon Sacred Heart Hospital, Chuncheon-si, Gangwon-do, Korea, Republic of
GangNeung Asan Hospital, Gangneung-si, Gangwon-do, Korea, Republic of
Yonsei University Wonju Severance Christian Hospital, Wonju-si, Gangwon-do, Korea, Republic of
... and 69 other locations.
A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B
Status: Recruiting
Last Changed: Dec 16, 2019
First Received: Nov 27, 2019
Disease(s): Chronic Hepatitis B
Intervention(s): TQ-A3334, Placebo, Entecavir Tablet
Locations: The second affiliated hospital of chongqing medical university, Chongqing, Chongqing, China
The first hospital of Jilin University, Changchun, Jinlin, China
Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis
Status: Recruiting
Last Changed: Jun 04, 2020
First Received: Apr 20, 2020
Disease(s): Hepatitis C Virus (HCV)
Locations: Samara Region HIV/AIDS Center /ID#222582, Samara, Russian Federation
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents
Status: Not yet recruiting
Last Changed: Jul 08, 2019
First Received: Mar 28, 2019
Disease(s): Chronic Hepatitis c
Intervention(s): Direct Acting Antivirals
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea
Status: Recruiting
Last Changed: Nov 17, 2020
First Received: Sep 20, 2016
Disease(s): Hepatitis C Virus
Intervention(s): Sofosbuvir
Locations: Konkuk University Chungju Hospital, Chungju-si, Chungcheongbuk-do, Korea, Republic of
Dankook University hospital, Cheonan-si, Chungcheongnam-do, Korea, Republic of
SoonChunHyang University Cheonan Hospital, Cheonan-si, Chungcheongnam-do, Korea, Republic of
Hallym University ChunCheon Sacred Heart Hospital, Chuncheon-si, Gangwon-do, Korea, Republic of
GangNeung Asan Hospital, Gangneung-si, Gangwon-do, Korea, Republic of
... and 70 other locations.
Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)
Status: Recruiting
Last Changed: May 07, 2018
First Received: Apr 18, 2018
Disease(s): Chronic Hepatitis C
Intervention(s): Non-Interventional
Locations: Local Institution, Beijing, Beijing, China
APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B
Status: Recruiting
Last Changed: May 18, 2020
First Received: Jul 13, 2018
Disease(s): Chronic Hepatitis B
Intervention(s): APG-1387 for Injection
Locations: Yifan Zhai, MD, Guangzhou, Guangdong, China
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)
Status: Not yet recruiting
Last Changed: Mar 25, 2019
First Received: Mar 25, 2019
Disease(s): Chronic Hepatitis C
Intervention(s): DAAs
A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors
Status: Recruiting
Last Changed: Oct 23, 2020
First Received: Jul 01, 2020
Disease(s): Chronic Hepatitis B
Intervention(s): ABI-H0731, Placebo, NrtI
Locations: California Liver Research Institute, Pasadena, California, United States
Schiff Center for Liver Disease, Miami, Florida, United States
Institute of Human Virology, Baltimore, Maryland, United States
Infectious Disease Care, Hillsborough, New Jersey, United States
Queen Mary Hospital, Hong Kong, Hong Kong
... and 3 other locations.
Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting
Status: Recruiting
Last Changed: Nov 21, 2019
First Received: Nov 14, 2018
Disease(s): Hepatitis C, Chronic
Locations: NSW Correctional Centres, Sydney, New South Wales, Australia